Preview

Epidemiology and Vaccinal Prevention

Advanced search

Recombinant Analogue of Varicella Zoster Virus Glycoprotein E: Cloning, Expression and Studying of AntigEn Properties

https://doi.org/10.31631/2073-3046-2016-15-1-77-85

Abstract

We made recombinant antigen GE containing fragment of VZV glycoprotein E (Gly48 - Glu135) fused to E. coli beta-galactosidase and confirmed its antigen specificity by Western blotting and competitive-inhibition enzyme immunoassay (EIA) in comparison with commercial analogues and natural viral antigens. We showed interaction of recombinant GE protein with IgG antibodies from rabbits immunized by vaccine viral strain. GE protein also specifically reacted in ELISA with 66% of sera from zoster patients and 35% of sera from control groups including sera containing antibodies to other herpes viruses, sera from healthy donors, and sera from patients with different forms of intestinal disorders. Consequently, we demonstrated possibility of application of our recombinant GE VZV as antigen for diagnostics and research use.

About the Authors

G. I. Alatortseva
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


A. V. Sidorov
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


L. N. Nesterenko
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


L. N. Luhverchik
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


I. I. Amiantova
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


V. V. Docenko
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


Phong Pham Huy
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


A. V. Milovanova
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


O. B. Vylivannaya
State BudgEtary Institution of Public Health«Diagnostic center of laboratory researches»
Russian Federation


A. C. Kazanova
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


V. V. Lavrov
Mechnikov Research Institute for Vaccines and Sera; State Educational Institution of Additional Professional Education «Medical Academy of Postgraduate Studies», Ministry of Healthcare of the Russian Federation
Russian Federation


V. V. Zverev
Mechnikov Research Institute for Vaccines and Sera
Russian Federation


References

1. Kuhn J. E., Klaffke K., Munk K., Braun R.W. 1990. HSV-1 gB and VZV gp-II crossreactive antibodies in human sera. Arch. Virol. 112: 203 – 213.

2. Kutinova L., Hainz P., Ludvikova V., Maresova L., Nemeckova S. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of varicella-zoster virus. Virology. 2001; 280: 211 – 220.

3. Montalvo E.A., Parmley R.T., Grose C. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of Nlinked and O-linked oligosaccharide moieties. J. Virol. 1985; 53: 761 – 770.

4. Haumont M., Jacquet A., Massaer M., Deleersnyder V., Mazzu P., Bollen A. et al. Purification, characterization and immunogenicity of recombinant varicellazoster virus glycoprotein gE secreted by Chinese hamster ovary cells. Virus Res. 1996; 40: 199 – 204.

5. Grahn A., Studahl M., Nilsson S., Thomsson E., Bäckström M., Bergström T. Varicella-Zoster Virus (VZV) Glycoprotein E Is a Serological AntigEn for Detection of Intrathecal Antibodies to VZV in Central Nervous System Infections, without Cross-Reaction to Herpes Simplex Virus 1. Сlinical and vaccine immunology. 2011; 18 (8): 1336 – 1342.

6. Alatortsev V.E., Alatortseva G.I. Strain of bacterium Escherichia coli used for ecombinant proteins preparing. Patent RF, № 2043409; 1995 (in Russian)

7. Alatortsev V.E., Alatortseva G.I. Vector pel5с designated for foreign DNA expression. Patent RF, № 20715031; 1997 (in Russian).

8. News in DNA cloning. A practical approach. Ed.: Glover D.M. Moscow; 1989: 122 – 128 (in Russian).

9. Sameh Magdeldin and Annette Moser. Affinity Cromatography: Principles and applications, affinity chromatography Ed.: dr. S. Magdeldin. In Tech. 2012: 70 – 75.

10. Virca G.D., Travis J., Hall P.K., Roberts R.C. Purification of α-2-Macroglobulin by chromatography on Cibacron Blue sepharose. Analytical Biochemistry. 1978; 8: 274 – 276.

11. Rattana Wongchuphan, Beng Ti Tey, Wen Siang Tan, Senthil Kumar Subramanian, Farah Saleena Taip, Tau Chuan Ling. Purification of rabbit polyclonal immunoglobulin G using anion exchangers. Process Biochemistry. 2011; 46: 101 – 107.

12. Practical Protein Chemistry. Ed. Darbre. A. 1989: 1 – 621 (in Russian).

13. Towbin H., Staehlin T., Gordon Y. Proc. nat. Acad. Sci. USA. 1979; 76: 4350 – 4359.

14. Ceroni A., Sibani S., Baiker A., Pothineni V.R., Bailer S.M., LaBaer J. et al. Systematic analysis of the IgG antibody immune response against Varicella zoster virus (VZV) using a self-assembled protein microarray. Mol Biosyst. 2010; 6 (9): 1604 – 1610. Doi: 10.1039/c003798b. Epub 2010 Jun 1.

15. Vizoso Pinto M. G., Pfrepper K.-I., Janke T., Noelting C., Sander M., Lueking A. et al. A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens Virology Journal. 2010; 7: 165.

16. Park R., Hwang J.Y., Lee K.I., Namkoong S., Choi .SK., Park S. et al. Measurement of antibodies to varicella-zoster virus using a virus-free fluorescent-antibodyto- membrane-antigen (FAMA) test Microbiol Biotechnol. 2015; 25 (2): 268 – 273.


Review

For citations:


Alatortseva G.I., Sidorov A.V., Nesterenko L.N., Luhverchik L.N., Amiantova I.I., Docenko V.V., Huy P.P., Milovanova A.V., Vylivannaya O.B., Kazanova A.C., Lavrov V.V., Zverev V.V. Recombinant Analogue of Varicella Zoster Virus Glycoprotein E: Cloning, Expression and Studying of AntigEn Properties. Epidemiology and Vaccinal Prevention. 2016;15(1):77-85. (In Russ.) https://doi.org/10.31631/2073-3046-2016-15-1-77-85

Views: 930


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)